Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

Interdisciplinary Training Programme for Clinicians in Translational Medicine and Therapeutics at the University of Cambridge: Support for the 2014 MPhil Appointments. (360G-Wellcome-085686_Z_08_K)

<table> <tbody> <tr> <td>We &nbsp; propose an innovative training scheme for Translational Medicine and &nbsp; Therapeutics (TMAT) which builds on the exceptional conjunction on the &nbsp; Cambridge campus of leading scientists and clinical specialists, with an &nbsp; industrial research environment embraced both by international pharmaceutical &nbsp; and local biotech companies. Much of this is found under the same roof, the &nbsp; Addenbrookes Centre for Clinical Investigation (ACCI), with a track record of &nbsp; integrated training: academic with industrial, clinical with scientific, &nbsp; pharmacology &amp; therapeutics with patient-based specialties. The novel &nbsp; TMAT programme will attract the brightest candidates at several levels of &nbsp; seniority, ranging from MB PhD students to clinical lecturers, some wishing &nbsp; translational skills in their chosen specialty, others not yet differentiated &nbsp; who may become future leaders and teachers of TMAT. Each trainee will have a &nbsp; customised programme. Part of this will be a bespoke, modular MSc modelled on &nbsp; the well-known small-group lectures and supervisions of the Cambridge final &nbsp; year undergraduate courses. However the centrepiece for most candidates will &nbsp; be a PhD including formal teaching in a wide range of translational and &nbsp; pharmacological skills, and a project which takes proof-of-concept studies in &nbsp; cell or animal systems forward to proof-of-concept studies in humans. We have &nbsp; assembled an outstanding faculty of PhD supervisors spanning a wide choice of &nbsp; skills and experience in basic and clinical science. All trainees will have &nbsp; the opportunity for hands-on exposure to the design and conduct of &nbsp; experimental medicine studies investigating the therapeutic potential of new &nbsp; drugs, in collaboration with our industrial partner, GlaxoSmithKline (GSK). &nbsp; Our product will be a new generation of clinician scientists with 360-degree &nbsp; vision of the complex landscape of modern therapeutic medicine, who can rise &nbsp; to the challenges and opportunities of 21st century drug development.</td> </tr> </tbody> </table>

£28,140

15 Dec 2014

Grant details
Amount Awarded 28140
Applicant Surname Brown
Approval Committee PhD Studentships in Translational Medicine and Therapeutics
Award Date 2014-12-15T00:00:00+00:00
Financial Year 2014/15
Grant Programme: Title Translational Medicine & Therapeutics Programme - Other Appointment
Internal ID 085686/Z/08/K
Lead Applicant Prof Morris Brown
Planned Dates: End Date 2015-09-30T00:00:00+00:00
Planned Dates: Start Date 2014-10-01T00:00:00+00:00
Recipient Org: Country United Kingdom
Region East of England
Additional data added by GrantNav